Trials stopped early: too good to be true?
Open Access
- 1 March 1999
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 353 (9157) , 943-944
- https://doi.org/10.1016/s0140-6736(98)00379-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trialThe Lancet, 1999
- Clinical Trial Data and Safety Monitoring BoardsCirculation, 1995
- Interim analysis: The alpha spending function approachStatistics in Medicine, 1994
- Monitoring of clinical trials: Issues and recommendationsControlled Clinical Trials, 1993
- When to stop a clinical trial.BMJ, 1992
- Practical problems in interim analyses, with particular regard to estimationControlled Clinical Trials, 1989
- Investigating Therapies of Potentially Great Benefit: ECMOStatistical Science, 1989
- The size of clinical trials in cancer research – what are the current needs?British Journal of Cancer, 1989
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976